PMID- 12628330 OWN - NLM STAT- MEDLINE DCOM- 20031017 LR - 20190916 IS - 0168-3659 (Print) IS - 0168-3659 (Linking) VI - 88 IP - 2 DP - 2003 Mar 7 TI - Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. PG - 229-42 AB - Biodegradable microcapsules for sustained release of recombinant human growth hormone (rhGH) were prepared by a solid-in-oil-in-water (S/O/W) emulsion solvent evaporation technique using lyophilized protein microparticles. The minimum mean particle size of rhGH in S/O dispersions was 2.8-3.0 microm when ammonium acetate was added at molar ratios of 10-20 times against rhGH. High entrapment of rhGH in microcapsules was achieved by incorporating rhGH powder with a smaller particle size obtained by lyophilizing with ammonium acetate. As the particle size of rhGH decreased, the in vivo initial release decreased, while subsequent serum levels of rhGH in sustained release phase were higher. Addition of zinc oxide to microcapsules resulted in higher serum levels than those prepared without zinc oxide, suggesting a stabilizing effect of zinc oxide after subcutaneous injection into rats. The release profile of rhGH from microcapsules was controllable by selecting the proper copoly(DL-lactic/glycolic)acid (PLGA) with L/G ratio and molecular weight. Utilization of rhGH powder with a smaller particle size obtained by lyophilizing with ammonium acetate is essential for preparation of microcapsules with high entrapment and well-controlled sustained release profile with small initial release. FAU - Takada, Shigeyuki AU - Takada S AD - Drug Formulation Research Laboratories, Takeda Chemical Industries, Ltd., 2-17-85, Juso-honmachi, Yodogawa-ku, Osaka 532-8686, Japan. takada_shigeyuki@takeda.co.jp FAU - Yamagata, Yutaka AU - Yamagata Y FAU - Misaki, Masafumi AU - Misaki M FAU - Taira, Keiko AU - Taira K FAU - Kurokawa, Tomofumi AU - Kurokawa T LA - eng PT - Journal Article PL - Netherlands TA - J Control Release JT - Journal of controlled release : official journal of the Controlled Release Society JID - 8607908 RN - 0 (Acetates) RN - 0 (Capsules) RN - 0 (Delayed-Action Preparations) RN - 0 (Emulsions) RN - 0 (Powders) RN - 0 (Solvents) RN - 9002-72-6 (Growth Hormone) RN - J41CSQ7QDS (Zinc) RN - RRE756S6Q2 (ammonium acetate) SB - IM MH - Acetates/chemistry MH - Animals MH - Capsules MH - Delayed-Action Preparations MH - Drug Compounding/methods MH - Emulsions MH - Freeze Drying MH - Growth Hormone/*administration & dosage/pharmacokinetics MH - Humans MH - Injections, Subcutaneous MH - Male MH - Microscopy, Electron, Scanning MH - Particle Size MH - Powders MH - Rats MH - Rats, Sprague-Dawley MH - Solvents MH - Zinc/administration & dosage/pharmacokinetics EDAT- 2003/03/12 04:00 MHDA- 2003/10/18 05:00 CRDT- 2003/03/12 04:00 PHST- 2003/03/12 04:00 [pubmed] PHST- 2003/10/18 05:00 [medline] PHST- 2003/03/12 04:00 [entrez] AID - S0168365902004947 [pii] AID - 10.1016/s0168-3659(02)00494-7 [doi] PST - ppublish SO - J Control Release. 2003 Mar 7;88(2):229-42. doi: 10.1016/s0168-3659(02)00494-7.